Skip to main content
. 2021 Oct 13;4:1196. doi: 10.1038/s42003-021-02728-4

Fig. 6. Neutralization analyses of convalescence sera from D614G-, B.1.1.7- and B.1.351- infected patients and vaccine-elicited sera.

Fig. 6

The procedures were identical to the methods used in animal serum neutralization analyses. a Mean neutralization ID50 values of different SARS-CoV-2 infected convalescence serum samples against pseudotyped SARS-CoV-2 variants. Red to blue indicates increased neutralization activity high to low as shown in the scale bar. b the ID50 ratios, compared with the D614G reference strain, are displayed using dot plots. c the ID50 ratios, compared with the B.1.1.7 variant, are displayed using dot plots. d the ID50 ratios, compared with the B.1.351 variant, are displayed using dot plots. Data are presented as means ± SEMs. Dashed lines indicate the threshold of fourfold difference. The experiments were repeated twice due to the sample limitation. e ID50 ratios of sera from inactived-vaccine, compared with the D614G reference strain, are displayed using dot plots. f ID50 ratios of sera from adenovirus-vaccine, compared with the D614G reference strain, are displayed using dot plots. b-f, data are presented as means ± SEMs. Asterisks indicate statistical significance.